Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study

Abstract

BackgroundType 2 diabetes mellitus (DM2) is a chronic disease, and for treatment to succeed, it is necessary to harmonize the mental health of the patient with the environment, which impacts quality of life and adherence to medical regimens. The objetive of this study is describe the quality of life of patients with DM2 and the factors relates to its modification.MethodsThis investigation was a cross-sectional study. Patients over 18 years of age with DM2 were selected. The following variables related to quality of life were studied: age, sex, occupation, marital status, years of DM2 evolution, comorbidities and presence of depression (Beck Depression Inventory). Perceived quality of life was measured with a health-related quality of life (HRQoL) scale, the 36-Item Short-Form Survey (SF-36). Patients were classified according to SF-36 HRQoL score (< 50, 51-75 and > 76 points).ResultsAmong the 1394 patients included, the median age was 62 years. Global HRQoL had a median of 50.1 points. Bivariate analysis showed that age, marital status, sex, occupation, comorbidities, duration of DM2 and comorbidities had impacts on HRQoL. The logistic regression model identified age (odds ratio [OR] 1.04) and depression (OR 4.4) as independent factors that influenced overall quality of life.ConclusionsPatients with DM2 have poor HRQoL, which is associated with a high frequency of depression. Older age and the presence of depression impair patient HRQoL.Trial registrationR-2013-781-052. Registered 20 December 2014.

Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life

“…Besides, as Projection involves the justification of aggression against external sources of frustration, such a defense mechanism might lead to the justifying of covert hostile and counter dependent behaviors, such as a bad lifestyle and reduced treatment adherence, in turn negatively affecting one's physical status. This is in line with previous findings regarding the high levels of frustration and anger in patients with T2DM, mainly due to restrictions on food and comorbidities in sexual life (Zurita-Cruz et al, 2018;Al Anazi et al, 2019).…”

Untitled

“…[8][9][10] Different studies reported that DM has a negative impact on the overall QoL of DM patients. [11][12][13][14] Nevertheless, as these studies, different tools were used among different populations; hence, it is still debatable to know the correct findings of the QoL of DM patients in different cohorts of patients in different countries. [11][12][13][14] There are two main types of research tools which usually use to measure QoL among DM patients, that is, generic or disease-specific.…”

Measurement of patient-reported outcomes. 1: The search for the Holy Grail

“…For example, the SF-36 covers some aspects of symptoms, functioning, and general health perceptions. At the same time the SF-36, and its many variants, are frequently referred to as measures of quality-of-life (QoL), which they clearly are not [3][4][5] . If researchers are unclear about what a PROM is intended to measure, the construct definition of the instrument is inadequate.…”